MS-325 injectable contrast agent for MRI: Metasyn's agent is in Phase I testing in healthy volunteers.

Metasyn Inc., Cambridge, Mass.

Read the full 43 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE